Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

National Institutes of Health

Federal funding opportunity PAR-25-145 published by National Institutes of Health. Review the official synopsis for eligibility, award terms, and application requirements.